Skip to content

PTSD: Is There Any Relief?

PTSD: Is There Any Relief?

In honor of PTSD awareness month, let’s take a look at the debilitating mental health condition and how medical marijuana could help.Post-traumatic stress disorder is a mental health condition caused by witnessing or experiencing a traumatic event. It is understandable for one to be taken aback and impacted by a traumatic event, but if specific symptoms tend to stick around and affect a patient’s day-to-day life, it is important to consider PTSD as a cause.

Core Symptoms

  • Re-experiencing the event through intrusive flashbacks and nightmares
  • Avoidance of places, people and activities that are reminders of the traumatic event
  • Emotional numbness
  • Feeling jumpy, irritable or angry

Current Treatments

The treatment of PTSD often involves a combination of psychotherapy and medications. Cognitive behavioral therapy (CBT) has been found to be particularly helpful for treating PTSD. While treating PTSD with psychotherapies like CBT and medications can show some results for specific symptoms, many have started to search for a better alternative. With increasing data and efficacy reports circulating, medical marijuana is stepping into the spotlight as a better solution to easing symptoms.

How Can Medical Marijuana Help?

Cannabinoids found in cannabis activate the two main cannabinoid receptors in the endocannabinoid system (CB1 and CB2), which in turn produces a wide range of impacts on the central nervous system. These effects dramatically help PTSD patients manage the main symptoms of their condition, which include re-experiencing, avoidance and numbness, and hyperarousal.    

Reduce anxiety:

Studies have shown that people suffering from PTSD have much lower levels of a neurotransmitter called anandamide, which stimulates the mood and operates as a natural antidepressant. Using medical cannabis jumpstarts the body’s endocannabinoid system where it is lacking, which reduces the anxiety and irritability experienced from PTSD.

Reduce insomnia and nightmares:

Cannabis can also help prevent nightmares by reducing the REM sleep. By doing so, the vivid dreams that occur during this stage subside allowing cannabis to relieve any recurring nightmares that are associated with the patient’s PTSD.

In fact, a study was conducted to test this hypothesis by utilizing a cannabinoid receptor stimulant called nabilone. This involved 47 patients who despite using antidepressants and seeing a psychiatrist regularly, continued to have recurring nightmares. Following treatment, 72% of patients stopped having nightmares or had their severity drastically reduced. (Health Care in America)

Along with reducing the number of terrifying nightmares with medical cannabis, patients also reported that the quality and duration of sleep improved, while daytime flashbacks and night sweats decreased. Findings like these are major developments in the potential proof that medical cannabis could serve as a much more effective role in conditions like PTSD.

Are you interested in exploring medical marijuana treatments for your patients? Join Arfinn Med for FREE to access peer-to-peer data on medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings

Sources:

https://www.mayoclinic.org/diseases-conditions/post-traumatic-stress-disorder/symptoms-causes/syc-20355967
https://healthcareinamerica.us/cannabis-key-treating-ptsd-b4abf432215
https://adaa.org/understanding-anxiety/posttraumatic-stress-disorder-ptsd/symptoms
https://parkridgehealth.com/blog/entry/post-traumatic-stress-disorder-ptsd-what-you-need-to-know

Stories you may be interested in

New study finds cannabis effective for treating migraines

A study published last month in the Journal of Pain found a statistically significant reduction in migraine and headache symptoms and recurrences among patients who used cannabis for treatment.Smoking cannabis reduced the severity and length of migraine episodes by nearly half. Researchers concluded that headache and migraine severity were reduced by nearly 50% after using cannabis. The study, conducted by researchers…
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More

Research shows cannabis can lower opioid dosage, but studies are preliminary

Larson cited one statistic to justify his bill: “Studies have shown up to 75% reduction in opioid dosage for medical cannabis users” The intersection of medical cannabis and opioid use as treatments for chronic pain is an emerging field of research as more states loosen regulations on medical and recreational use of marijuana. But does…
Read More

Scientists Discover Two New Cannabinoids

The plant Cannabis sativa produces more than 400 chemicals, but only one, THC, gets you high. Or so it seems. A group of Italian researchers announced on December 30th the discovery of two new cannabinoids, chemicals produced by weed like THC and CBD. The first, tetrahydrocannabiphorol (THCP), is allegedly 30 times more potent than THC, they claim.…
Read More

Customize Your Patient Notes with Arfinn Med

Joining the text messaging update, the Arfinn Med portal now presents the ability to create note taking templates. This innovative addition will allow physicians to streamline the data and information that they are collecting from patients, resulting in their cases staying aligned and concise. Additionally, through this function, physicians will be able to pick and…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Leave a Comment

You must be logged in to post a comment.